MULTI-STAKEHOLDER DISCUSSIONS
The CDDF offers workshops, conferences and webinars that bring stakeholders involved in cancer drug development into a productive dialogue in a neutral, non-competitive space. The CDDF holds multiple activities and initiatives in collaboration with regulators from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) and other regulatory agencies, academic researchers from around the globe, pharmaceutical companies, and patient advocates.
The Cancer Drug Development Forum (CDDF) Annual Conference is a unique multi-stakeholder meeting. This interactive 3-day conference offers plenary lectures with moderated discussions, including case studies and networking opportunities. In addition to the Annual Conference, the CDDF organises workshops to facilitate multi-stakeholder collaboration to address topical issues in the cancer research field.
Upcoming events
Past events
Multi-Stakeholder Platform Advisory Group – Accelerating Clinical Trials in the EU
The CDDF takes part in the Multi-Stakeholder Platform Advisory Group (MSP AG) under the Accelerating Clinical Trials in the EU (ACT EU). As an ad hoc representative of MSP AG, the CDDF provides multi-stakeholder input on key topics in drug development and collaborate with regulators and other stakeholders to enhance clinical trials within the European landscape.
CDDF Diversity Initiative
The CDDF has launched its Diversity Initiative in August 2024 to examine parameters of inclusion/diversity to support planning and evaluation of clinical research and the applicability of clinical trial outcomes to Europe’s diverse population. This initiative is a CDDF-sponsored and directed project with a multi-stakeholder working group of regulators, payers, patients, academic researchers, and pharmaceutical companies.